Rolland Gyulai
Overview
Explore the profile of Rolland Gyulai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
470
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gyulai R
J Eur Acad Dermatol Venereol
. 2025 Feb;
39(3):449-450.
PMID: 39996341
No abstract available.
2.
Pozsgai M, Sebastian U, Olah P, Nemeth V, Gyulai R, Lengyel Z
Int J Dermatol
. 2025 Feb;
PMID: 39925013
Background: The introduction of immune checkpoint inhibitors (ICIs) opened a new era in cancer immunotherapy. In particular, PD-1 inhibitors have shown remarkable efficacy in various cancers, most notably melanoma. However,...
3.
Szabo K, Balogh F, Romhanyi D, Erdei L, Toldi B, Gyulai R, et al.
Int J Mol Sci
. 2025 Jan;
26(2).
PMID: 39859154
Epigenetic mechanisms are central to the regulation of all biological processes. This manuscript reviews the current understanding of diverse epigenetic modifications and their role in the establishment and maintenance of...
4.
Bozo R, Flink L, Ambrus B, Ghaffarinia A, Koncz B, Kui R, et al.
Int J Mol Sci
. 2024 Oct;
25(20).
PMID: 39457071
In the psoriatic non-lesional (PS-NL) skin, the tissue environment potentially influences the development and recurrence of lesions. Therefore, we aimed to investigate mechanisms involved in regulating tissue organization in PS-NL...
5.
Rozsa P, Degovics D, Baltas E, Gyulai R, Kemeny L
Int J Dermatol
. 2024 Mar;
63(8):1089-1090.
PMID: 38514896
No abstract available.
6.
Rozsa P, Varga E, Gyulai R, Kemeny L
Int J Dermatol
. 2024 Mar;
63(9):1256-1257.
PMID: 38505949
No abstract available.
7.
Mezolaki N, Baltas E, Ocsai H, Varga A, Korom I, Varga E, et al.
Melanoma Res
. 2023 Nov;
34(1):54-62.
PMID: 37962233
We hypothesise that regression may have an impact on the effectiveness of adjuvant IFN therapy, based on its role in the host immune response. Our purpose is to investigate regression...
8.
Szlavicz E, Szabo A, Kinyo A, Szeiffert A, Bancsok T, Brodszky V, et al.
Qual Life Res
. 2023 Oct;
33(1):101-111.
PMID: 37787930
Objectives: Two bolt-on dimensions (skin irritation, self-confidence) have been developed for the EQ-5D-5L to improve its content validity and responsiveness in psoriasis. However, the two bolt-ons are not strictly psoriasis-specific...
9.
Kadar Z, Lengyel Z, Gyulai R
Magy Seb
. 2023 May;
76(1):39-47.
PMID: 37130027
Melanoma surgery has changed significantly in recent years. The highly radical operations with many complications, in addition to which the complete and disease-free survival remained low, were gradually replaced by...
10.
Szebenyi J, Legradi M, Nemeth C, Joura M, Gyulai R, Lengyel Z
Dermatologie (Heidelb)
. 2023 Mar;
74(4):232-242.
PMID: 36897374
The dermoscope was initially used in dermatology to distinguish between pigmented and nonpigmented tumors, both benign and malignant. Over the last two decades, however, the spectrum of dermoscopy has broadened...